As the global biopharmaceutical industry works to combat the coronavirus pandemic, the TeraPore team is mindful that our work to advance innovative nanofiltration technologies is more important than ever. We are steadfast in our commitment to developing precision bioseparation solutions that solve complex manufacturing challenges and enhance the safety of advanced therapeutics and biologics, including future COVID-19 treatments, diagnostics, and vaccines.
Pioneering a new generation of precision bioseparation solutions to meet the challenges of drug manufacturing – today and tomorrow
TeraPore is answering the call for innovation in bioprocessing through the development of high-capacity, high-yield bioseparation solutions that are well-suited to the demanding and precise manufacturing requirements of advanced therapeutics and novel biologics. Our Intelligent Membrane™ platform is a leap forward from conventional separations technologies, providing targeted and uniform nanofiltration capabilities that are engineered to tackle the most difficult bioseparation challenges.